NCT06954389View on ClinicalTrials.gov

Hyperbaric Oxygen Therapy as a Neuroprotective Modality in Pediatric Acquired Brain Injury With Motor Disability

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2024

Conditions
Hyperbaric Oxygen TherapyNeuroprotectivePediatricAcquired Brain InjuryMotor Disability
Interventions
OTHER

Hyperbaric oxygen therapy

Patients received hyperbaric oxygen therapy using a monochamber hyperbaric chamber in addition to conventional rehabilitation.

OTHER

Conventional rehabilitation

Patients received conventional rehabilitation alone.

Trial Locations (1)

33516

Kafrelsheikh University, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER

NCT06954389 - Hyperbaric Oxygen Therapy as a Neuroprotective Modality in Pediatric Acquired Brain Injury With Motor Disability | Biotech Hunter | Biotech Hunter